Column Group LLC Long-Term Concentrated

CIK: 0001833486 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $539,375 (100.0% shares, 0.0% debt)

Holdings (7)

— NGM Biopharmaceuticals Inc 45.9%

Value ($000) $247,749 Shares 16,245,817 Est. Cost $29.51 Unrealized —

TNYA Tenaya Therapeutics, Inc. 20.5%

Value ($000) $110,735 Shares 9,400,290 Est. Cost $21.49 Unrealized -43.7%

RVMD Revolution Medicines Inc 15.8%

Value ($000) $85,388 Shares 3,347,245 Est. Cost $39.54 Unrealized -45.0%

— RAPT Therapeutics Inc 5.7%

Value ($000) $30,830 Shares 1,402,008 Est. Cost $19.75 Unrealized —

— Surrozen, Inc. 5.3%

Value ($000) $28,339 Shares 9,414,795 Est. Cost $7.07 Unrealized —

ORIC ORIC Pharmaceuticals Inc. 3.5%

Value ($000) $19,054 Shares 3,568,181 Est. Cost $28.69 Unrealized -68.6%

— eFFECTOR Therapeutics Inc 3.2%

Value ($000) $17,280 Shares 4,309,329 Est. Cost $14.05 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	NGM Biopharmaceuticals Inc	16,245,817	$247,749	45.9%	$29.51	—	COM	62921N105
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$110,735	20.5%	$21.49	-43.7%	COM	87990A106
RVMD	Revolution Medicines Inc	3,347,245	$85,388	15.8%	$39.54	-45.0%	COM	76155X100
—	RAPT Therapeutics Inc	1,402,008	$30,830	5.7%	$19.75	—	COM	75382E109
—	Surrozen, Inc.	9,414,795	$28,339	5.3%	$7.07	—	COM	86889P109
ORIC	ORIC Pharmaceuticals Inc.	3,568,181	$19,054	3.5%	$28.69	-68.6%	COM	68622P109
—	eFFECTOR Therapeutics Inc	4,309,329	$17,280	3.2%	$14.05	—	COM	28202V108